Bipartisan group pushes CMS to expand coverage for Alzheimer’s treatments
By
Kimberly Bonvissuto
Feb 21, 2023
Access to federally approved monoclonal antibody and other disease-modifying therapies for Alzheimer’s disease will be “extremely limited” unless the Centers for Medicare & Medicaid Services reconsiders...
Senior living community fined $10,000 after sending live resident to funeral home
By
Kimberly Bonvissuto
Feb 07, 2023
An Iowa memory care community is facing a $10,000 fine after wrongly declaring a resident dead and transferring her to a funeral home, where she was discovered alive and gasping for air inside a body bag.
Pandemic-linked decline in cancer screening persisted Into 2022
Feb 06, 2023
Low-dose computed tomographic scan rates and mammography rates were lower than expected during March 2021 to February 2022.
Alzheimer’s research, treatments prioritized in 2 bills taken up by Congress
By
Kimberly Bonvissuto
Feb 06, 2023
Two bipartisan bills prioritizing Alzheimer’s research and supporting scientists in the development of treatments for the disease were reintroduced in Congress last week.
ARPA-funded projects aim to collect data on assisted living, help retain workers
By
Kimberly Bonvissuto
Feb 02, 2023
Efforts to track data on assisted living communities, retain workers and encourage planning for long-term care are among the projects receiving technical assistance from a national nonprofit to launch...
Two disease processes contribute to age-related macular degeneration
Jan 13, 2023
Lesions from soft drusen/pigment epithelial detachments have lower mean quantitative autofluorescence, whereas those from subretinal drusenoid deposits have higher.
Agency staffing cost assisted living providers $4 million in one state in 2022: report
By
Kimberly Bonvissuto
Jan 04, 2023
Although assisted living communities in Tennessee tapped healthcare staffing agencies less frequently than nursing homes during the COVID-19 pandemic, providers in the sector collectively were on a trajectory...
More news for Tuesday, Dec. 13
By
Kimberly Bonvissuto
Dec 13, 2022
Lawmakers call for improved access to brain scans in diagnosing Alzheimer’s disease … Federal judge strikes down Montana vaccine choice law in healthcare settings … Juniper Communities receives SageCare...
Study looks at extent of residual lung abnormalities after COVID-19 hospitalization
Dec 02, 2022
The posthospitalization prevalence of residual lung abnormalities was estimated at 11.7% in sensitivity analyses.
Alzheimer’s experts throw support behind experimental drug despite adverse events, deaths
By
Kimberly Bonvissuto
Dec 01, 2022
Alzheimer’s disease experts are throwing their support behind the drug lecanemab, despite reports of two deaths tied to the experimental monoclonal antibody medication.